# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Malignant mesenchymal tumor

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 91-100 of 516 results.
Genetic and Telomere Characteristics of High of Grade Soft Tissue Sarcomas
Status: Recruiting
Last Changed: Feb 07, 2019
First Received: Sep 11, 2015
Disease(s): Soft Tissue Sarcoma
Locations: University Hospitals of Leicester NHS Trust, Leicester, Leicestershire, United Kingdom
Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy
Status: Recruiting
Last Changed: Jun 07, 2019
First Received: Mar 22, 2018
Disease(s): Sarcoma,Soft Tissue
Intervention(s): Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery, 2 cycles of atezolizumab followed by surgery then post-operative radiotherapy, Pre-operative radiotherapy followed by surgery then 2 cycles of atezolizumab.
Locations: Institut Bergonie, Bordeaux, France
Centre Léon Bérard, Lyon, France
Institut Claudius Regaud, Toulouse, France
Institut Gustave Roussy, Villejuif, France
Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib
Status: Recruiting
Last Changed: Sep 24, 2019
First Received: Nov 08, 2018
Disease(s): Soft Tissue Sarcoma Adult
Intervention(s): pazopanib or guideline conform chemotherapy
Locations: Sarkomzentrum Berlin-Brandenburg, Bad Saarow, Germany
Charite, Berlin, Germany
Vivantes Klinikum Spandau, Berlin, Germany
Universitätsklinikum Dresden, Dresden, Germany
Uniklinik Frankfurt, Frankfurt, Germany
... and 6 other locations.
Proton or Photon RT for Retroperitoneal Sarcomas
Status: Recruiting
Last Changed: Dec 11, 2019
First Received: Aug 07, 2012
Disease(s): Retroperitoneal Sarcoma
Intervention(s): IG-IMPT, IG IMRT
Locations: Rush University Medical Center, Chicago, Illinois, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
Washington University School of Medicine Siteman Cancer Center West County, Creve Coeur, Missouri, United States
... and 6 other locations.
Efficacy and Safety of Trabectedin (Yondelis®) in Patients With Advanced Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Nov 16, 2018
First Received: Feb 20, 2015
Disease(s): Soft Tissue Sarcoma
Intervention(s): trabectedin
Locations: Dokusan GmbH und Co. KG; Praxisklinik Herne / Onkologie, Herne, Nordrhein-Westfalen, Germany
MVZ Marien-Hospital-Wesel GmbH, Wesel, Nordrhein-Westfalen, Germany
Onkologische Gemeinschaftspraxis Dr. med. Mohm & Dr. med. Prange-Krex, Dresden, Sachsen, Germany
Praxis Dr. med. Jens Uhlig, Naunhof, Sachsen, Germany
Praxis für Innere Medizin, Hämatologie u. Onkologie, Bremen, Germany
... and 1 other locations.
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
Status: Recruiting
Last Changed: Sep 19, 2019
First Received: Nov 29, 2017
Disease(s): Sarcoma, Osteoid Sarcoma, Ewing Sarcoma
Intervention(s): Sarcoma-specific CAR-T cells
Locations: Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226)
Status: Recruiting
Last Changed: Dec 18, 2019
First Received: Aug 09, 2018
Disease(s): Alveolar Soft Part Sarcoma
Intervention(s): GB226
Locations: Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma
Status: Not yet recruiting
Last Changed: Jan 03, 2020
First Received: Jan 03, 2020
Disease(s): Sarcoma,Soft Tissue
Intervention(s): Cobimetinib, Atezolizumab
Locations: Institut de Cancérologie de l'Ouest, Angers, France
Centre Oscar Lambret, Lille, France
Centre Léon Bérard, Lyon, France
Hôpital de la Timone, Marseille, France
Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma
Status: Recruiting
Last Changed: May 06, 2019
First Received: Oct 23, 2017
Disease(s): Metastatic Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma
Intervention(s): Durvalumab and Tremelimumab, Doxorubicin
Locations: Medizinische Hochschule Hannover, Hannover, Germany
SAINT:Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Sep 06, 2018
First Received: May 03, 2017
Disease(s): Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma
Intervention(s): Trabectedin, Ipilimumab, Nivolumab
Locations: Sarcoma Oncology Research Center, Santa Monica, California, United States